Leonard S. Schleifer, President & CEO at REGENERON PHARMACEUTICALS INC (REGN), sold 45,817 shares at $400.22 ($18.3M) on 2014-11-12, disclosed to the SEC on 2014-11-12.
Scheduled sale ($18.3M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $400.00 | 3,493 | $1.4M | 7.6% |
| 2 | $400.22 | 37,464 | $15.0M | 81.8% |
| 3 | $401.12 | 4,860 | $1.9M | 10.6% |
| Total | $400.30 avg | 45,817 | $18.3M | 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |